Free Trial

Panbela Therapeutics (PBLA) SEC Filings & 10K Form

Panbela Therapeutics logo
$0.28 +0.02 (+5.66%)
As of 04/17/2025 11:28 AM Eastern

Recent Panbela Therapeutics SEC Filings

DateFilerForm TypeView
02/04/2025
3:02 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
3:02 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:50 PM
Panbela Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/19/2024
5:40 PM
Nant Capital, LLC (Reporting)
Panbela Therapeutics (Issuer)
SOON-SHIONG PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:59 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
4:00 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
4:01 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
4:02 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
4:03 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
4:04 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
4:05 PM
Panbela Therapeutics (Filer)
Form 424B3
11/18/2024
3:16 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
5:00 AM
Panbela Therapeutics (Filer)
Form 424B3
11/15/2024
5:15 AM
Panbela Therapeutics (Filer)
Form 424B3
11/15/2024
5:03 AM
Panbela Therapeutics (Filer)
Form 424B3
11/15/2024
5:06 AM
Panbela Therapeutics (Filer)
Form 424B3
11/15/2024
5:09 AM
Panbela Therapeutics (Filer)
Form 424B3
11/15/2024
5:12 AM
Panbela Therapeutics (Filer)
Form 424B3
11/15/2024
5:12 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
6:40 PM
Nant Capital, LLC (Filed by)
Panbela Therapeutics (Subject)
Form SC 13D
10/29/2024
6:38 PM
Nant Capital, LLC (Reporting)
Panbela Therapeutics (Issuer)
SOON-SHIONG PATRICK (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/29/2024
8:24 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
8:24 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
8:25 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
8:25 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
8:26 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
8:26 AM
Panbela Therapeutics (Filer)
Form 424B3
10/29/2024
8:27 AM
Panbela Therapeutics (Filer)
Form 424B3
10/28/2024
4:16 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:26 PM
Horvath Susan (Reporting)
Panbela Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
3:34 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
4:25 PM
Panbela Therapeutics (Filer)
Form S-1/A
08/13/2024
7:39 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
7:40 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
7:42 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
7:43 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
7:45 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
7:46 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
7:47 PM
Panbela Therapeutics (Filer)
Form 424B3
08/13/2024
4:08 PM
Panbela Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2024
4:30 PM
Panbela Therapeutics (Filer)
Form 424B3
Claim Your FREE Protection Guide (Ad)

In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code... And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos. But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition...

Click Here to Claim Your FREE Trump 100-Day Strategy Guide Now →
07/30/2024
3:59 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
3:46 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
6:00 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:21 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
7:22 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
7:24 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
7:27 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
7:29 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
3:16 PM
Panbela Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
3:35 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
8:09 AM
Nasdaq Stock Market LLC (Filed by)
Panbela Therapeutics (Subject)
Form 25-NSE
04/22/2024
7:02 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
3:31 PM
Panbela Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PBLA) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners